A bench headed by the Chief Justice of India suggests Squibb to conduct a mapping exercise of Zydus product with their claimed patent to ascertain infringement, if any.
Cancer imposes catastrophic health expenditure in India, with medicines constituting over 60% of out-of-pocket expenditure. Research shows wide price variations, limited cost containment.
Report commissioned by govt analysed cost-effectiveness of 2 medicines, comparing them to to chemo in patients with newly diagnosed advanced or metastatic non-small cell lung cancer.
Centre moves to reduce costs of trastuzumab deruxtecan, osimertinib & durvalumab, all 3 by British-Swedish pharma giant AstraZeneca. Doctors seek exemptions for more such drugs.
Beneath the uniform and the gallantry award was a man of rare humility. There was no trace of bravado in Colonel Sonam Wangchuk, no attempt to wear his achievements on his sleeve.
We now live in a world order that will keep shifting. India must use this window. This also means we remain disciplined enough not to be knee-jerked into reacting to what Pakistan sees as its moment in the sun.
COMMENTS